Nephros, a water filtration technology company, announced an 18% increase in net revenue to $5.6 million for Q3 2026, with net income rising to $0.5 million. The company expanded its active customer sites to a record 1,766, driven mainly by healthcare and commercial markets. Nephros also highlighted growth in service revenue and educational initiatives through its Water Institute, aiming to boost market presence and customer engagement. Despite economic uncertainties, Nephros remains profitable and focused on growth, with trailing twelve-month revenue surpassing $21 million.
Nephros reported an 18% increase in net revenue to $5.6 million for Q3 2026, alongside growth in net income and customer sites. For readers following the health sector, here is Pluang's market snapshot as of Nov 06, 2026 04:11 WIB: out of 150 priced US health stocks, 16 rose and 134 fell. Notable movers include INO at USD 1.26 with a 22.22% drop, FLNA at USD 0.46 down 21.02%, and XRAY at USD 8.82 down 17.18%.
Blast Bridge's total value locked (TVL) dropped sharply by about 84% from $41.04 million on Oct. 26 to $6.51 million on Nov. 3, reflecting a significant withdrawal of assets from its contracts. The platform announced its wind-down on Oct. 2, citing o...
Loma Negra, Argentina's leading cement producer, reported a net profit of Ps. 14.5 billion for Q3 2026, reversing a loss of Ps. 11.5 billion in the same period last year. Despite a 3.2% decline in net sales mainly due to weaker concrete segment reven...
Saul Centers reported Q3 2026 revenue of $78.4 million, up from $72 million a year earlier, driven by higher rents and property leasing. However, net income declined to $12.6 million from $14 million, mainly due to $3.7 million in costs related to th...
Shares of major cybersecurity companies like CrowdStrike, Okta, Cloudflare, and Palo Alto Networks dropped sharply on Thursday, falling 8-10% amid a broad tech market selloff. These stocks, once seen as resilient and benefiting from AI growth, faced ...
Shoulder Innovations, a medical tech company focused on shoulder surgical care, reported a 38% increase in Q3 2026 revenue to $16.2 million, driven by higher implant sales and prices. The company raised its 2026 revenue guidance to $68-$70 million, r...
